Weed (BUDZ) Capital Expenditures Growth (3y) (2020 - 2021)

Weed (BUDZ) Capital Expenditures Growth (3y) (2020 - 2021) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex Growth (3y) (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-4.39%
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-11.01%
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-0.22%
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	34.19%
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-8.00%
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	4.68%
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-7.72%
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Weed	3.13 Mn	3.13 Mn	-	-

Download Data